Your browser doesn't support javascript.
loading
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.
Abbott, Rebecca C; Iliopoulos, Melinda; Watson, Katherine A; Arcucci, Valeria; Go, Margareta; Hughes-Parry, Hannah E; Smith, Pete; Call, Melissa J; Cross, Ryan S; Jenkins, Misty R.
Affiliation
  • Abbott RC; Immunology Division The Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Iliopoulos M; The Department of Medical Biology University of Melbourne Parkville VIC Australia.
  • Watson KA; Immunology Division The Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Arcucci V; Immunology Division The Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Go M; Immunology Division The Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Hughes-Parry HE; Structural Biology Division The Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Smith P; Immunology Division The Walter and Eliza Hall Institute of Medical Research Parkville VIC Australia.
  • Call MJ; The Department of Medical Biology University of Melbourne Parkville VIC Australia.
  • Cross RS; Myrio Therapeutics Blackburn North, Melbourne VIC Australia.
  • Jenkins MR; The Department of Medical Biology University of Melbourne Parkville VIC Australia.
Clin Transl Immunology ; 12(3): e1440, 2023.
Article in En | MEDLINE | ID: mdl-36890859
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Transl Immunology Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Transl Immunology Year: 2023 Type: Article